Top Chicago, IL Biotech Companies (37)
Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of clinical and molecular data, and an operating system to make that data accessible and useful, Tempus enables physicians to make near real-time, data-driven decisions to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com.
PF is a consulting firm providing biomanufacturing strategy and execution. Our services include turnkey capital projects and facility builds; owner's representation and program/project management; validation; quality, regulatory and compliance; engineering and automation and more. We partner with startup and established pharmaceutical companies, advanced therapy companies, academia, hospitals, financial institutions, and CROs/CMOs. One of our core values is giving back. Volunteering at hospitals, supporting healthcare-related fundraisers and partnering with nonprofit organizations is an integral part of our culture. In doing so, not only do we raise awareness of many life-threatening diseases, but we also bring our team and our client’s team closer to the actual patients and families that will be impacted by our work. Project Farma is a Precision for Medicine company and part of Precision ADVANCE, the cell & gene therapy collective™ (https://www.precisionmedicinegrp.com/advance/)
Trusted by the world's leading organizations, Point B is a consulting firm that works at the intersection of expertise, industry insight, and transformative technology. This collaborative approach enables you to solve your most important challenges, by bringing together the right mix of talent and technology to deliver greater value and impact. With over 850 associates in the US and 3000+ consultants around the world through our Nextcontinent partnership, we work where you do to deliver the change you seek.
Established in 2001, Avalere Health is a purposefully built commercialization partner for the biopharmaceutical, medical technology, and wellness industries. Our team of 1,500+ experts combine their knowledge and expertise across our core disciplines—Consulting; Medical; Policy; Value, Evidence, and Access; Marketing; and Digital Experience Technology—to create the connections that make better health happen. We partner with our clients to navigate the complex and rapidly changing healthcare ecosystem. Together, our experts help clients connect patients with life-changing therapies, realizing the potential of strategies and solutions to accelerate innovation that improves lives.
CancerIQ helps providers use genetic information to predict, pre-empt, and prevent disease - starting with cancer. By making is easier to identify patients at risk, offer genetic evaluations at point of care, and design a tailored cancer prevention plan - we can help healthcare systems get ahead of this costly and emotionally devastating disease.
UL Research Institutes is a leading independent safety science organization with global reach. Dedicated to exploring vital questions related to public safety, we sense and act on risks to humanity and our planet. Since 1894, our trusted research has engaged the ingenuity of top minds across scientific disciplines to engineer a safer and more sustainable world. Science builds the knowledge required to mitigate increasingly urgent safety problems like environmental and chemical pollution and artificial intelligence inequities — and our rigorous, objective investigations uncover and develop that knowledge. In collaboration with a global network of scientists and safety professionals, we define the safe and sustainable use of things ranging from legacy materials and devices to new and emerging technologies. Our discoveries support the development of practical standards and policies by UL Standards & Engagement. Together, we are advancing safety science for the greater good. Discover more at UL.org.
Pioneering Diagnostics A world leader in the field of in vitro diagnostics for over 55 years, bioMérieux is present in 44 countries and serves more than 160 countries with the support of a large network of distributors. In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France. bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. bioMérieux is listed on the Euronext Paris stock market.
It’s not a debate. There’s no two sides. A post-pollution world is inevitable. Humans will either be part of it, or the planet will go on without us. In other words, it’s defossilize or die. But where others see a dire choice, LanzaTech sees a trillion-dollar opportunity. The good news is after 15 years, north of a thousand patents, and millions of hours of pioneering scientific inquiry, LanzaTech has invented a technology big enough to meet the moment. One that transforms pollution into profit, and ensures that humans continue to prosper far into the post-pollution future. The science is state-of-the-art, but the idea is simple. We use nature to heal nature. First we capture carbon emissions. Then we feed them into bioreactors where trillions of carbon-hungry microbes go to work. These tiny dynamos eat the pollution and output valuable raw material commodities. Pure enough to be resold, repurposed, recycled, renewed, re-everythinged — from sustainable jet fuel to yoga pants. It’s a commercial scale solution that’s ready for market today. In a crowded sector filled with speculation but short on results, our plug-and-play platform is already making our customers money. Turns out science and business makes one helluva team. Waste carbon pollution is humanity’s biggest threat. LanzaTech is turning it into an opportunity. Reducing emissions and making money for our customers — today. Let's transform our tired Lose-Lose climate debate into a Win-Win proposition. One that helps companies grow their revenue while helping the planet reach a post-pollution reality.
rMark Bio applies propriatary analytics to help pharmaceutical companies identify academic researchers to partner with during new drug research and development. Our solution reduces the man hours wasted manually gathering and understanding info about academic scientists, while simultaneously providing higher value partnership opportunities.
Hazel Technologies develops products that extend the shelf life of produce. Our customers include some of the largest produce growers in the world.
As a global partner to the biopharmaceutical industry, Asahi Kasei Bioprocess helps biologics manufacturers safely and efficiently produce medicines that patients can trust, by dependably supplying innovative yet exceptionally reliable bioprocess consumables, equipment and scientific support services. Our portfolio is anchored by Planova™ virus removal filters. First released in 1989 as the world's first hollow fiber filter developed specifically for removing viruses from biotherapeutic drug products, Planova™ filters ensure viral safety of biopharmaceutical drug products, thanks to their high quality and consistent performance. Leveraging 30 years of experience, we continue to provide our customers with products, services and expertise to achieve assurance that is beyond expectation. As part of our dedication to solving therapeutic product safety, efficiency and purity challenges, we also manufacture a comprehensive suite of downstream equipment. With technology platforms for virus filtration, chromatography, inline buffer formulation and oligonucleotide synthesis, our bioprocessing systems, columns and automation solutions advance GMP manufacturing of critical drug substances around the world. Our portfolio of market-driven equipment and cutting-edge technology touches unit operations across a wide range of therapeutic modalities, including classical small molecule pharmaceuticals, current-generation antibodies, plasma derivatives and next-generation oligonucleotide therapeutics.
Planet Pharma was founded by a dedicated team of seasoned professionals with extensive experience supporting the pharmaceutical, biotechnology and device industries. Our goal was to create an organization that strengthens the employer-employee dynamic by connecting clients with talent — ultimately making staffing more personal and creating enduring, valuable relationships. We are able to achieve this by leveraging cutting-edge technology and flexible service delivery models that enable us to provide personalized solutions. At Planet Pharma, the decision makers are at the table, with the tools and expertise to go beyond expectations. We have offices throughout the United States and Europe. All locations operate with shared attributes that are at the heart of everything we do: Innovative – We constantly explore new ways of working that will help us be more efficient and effective Entrepreneurial – We look at things differently, immerse ourselves in your world and devise solutions for each and every client Expert – Everyone on our team is an expert in their field, trained and continually learning to deliver an unrivaled level of experience Passionate – We are all incredibly proud to be part of Planet Pharma and we genuinely care about the people we work with We provide the following solutions: Contract Staffing, Outsourced Projects, Permanent Placement and Managed Service Provider Specialties: Clinical & Scientific Staffing, Technology Staffing, Site Management & Monitoring, Clinical Project & Program Management, Clinical Programming & Data Management, Biostatistical Analysis & Reporting, Pharmacovigilance, Medical Writing, Regulatory Affairs, Quality Assurance and Validation.
MAIA Biotechnology is a targeted therapy, immune-oncology company, focused on development and commercialization of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. A privately-held company based in Chicago, MAIA is led by a passionate, principled and highly experienced Management Team with significant drug development experience, committed to advancing promising agents into trials in humans clinical trials. MAIA’s business strategy is designed to advance a strong value proposition for its portfolio of potentially novel compounds. MAIA controls risk and enhances its opportunity for success by diversifying and generating this portfolio of assets with a variety of compounds with novel mechanisms of action which have potential activity in multiple tumor types. MAIA’s business model involves placing drug candidates in their own dedicated, R&D focused subsidiary company, which is supported by the common infrastructure, management team, and resources of the MAIA enterprise. This model allows MAIA to provide more focused R&D support to each drug candidate, while also distributing shared central resources among subsidiary companies to maintain a lean, capital-efficient operating structure.
Belay Diagnostics provides next-gen sequencing to detect aneuploidy and mutations with our cerebrospinal fluid testing platform. Improving diagnosis for brain and spinal cord cancers can give people the best chance for a cure without the need for invasive biopsies. We see our technological advances in cerebrospinal fluid assays as offering clinicians alternative diagnostic tools for use in treatment decisions.
IDEX (NYSE: IEX) is a company that has undoubtedly touched your life in some way. In fact, IDEX businesses make thousands of products that are mission-critical components in everyday activities. Chances are the car you’re driving has a BAND-IT® clamp holding your side airbag safely in place. If you were ever in a car accident, a Hurst Jaws of Life® rescue tool may have saved your life. If you or a family member is battling cancer, your doctor may have tested your DNA in a quest to find the best targeted medicine for you. It’s likely your DNA test was run on equipment that contains components made by our growing IDEX Health & Science team.
Citrine Informatics is the award-winning materials informatics platform for data-driven materials and chemicals development. It won the 2017 World Materials Forum Start-up Challenge, the 2018 AI Breakthrough award as the "Best AI-based Solution for Manufacturing," and 2020-2021 Cleantech 100 honors. The Citrine Platform combines smart materials data infrastructure and AI, which accelerates development of cutting-edge materials, facilitates product portfolio optimization, and codifies research IP, enabling its reuse and preventing its loss. Citrine's customers include Panasonic, Michelin, LANXESS, and some of the biggest and most respected names in the materials and chemicals industry in Asia, North America, and Europe.
Jivana Biotechnology is a preclinical-stage biotechnology company
Providing patients with comprehensive and compassionate care since 1987, Orsini is the leading, independent specialty pharmacy focused on rare diseases, gene therapies, and complex conditions. Orsini’s high-touch care model centers around compassionate, therapy-specific care teams who provide personalized care to patients based on their specific condition and treatment. The company’s comprehensive solutions include medication adherence programs, data analytics, customized manufacturer programs, and nationwide nursing coverage for convenient in-home infusion services. Headquartered in Elk Grove Village, IL, Orsini Specialty Pharmacy holds accreditations with the Accreditation Commission for Health Care (ACHC), The Joint Commission, URAC, NABP, and ACHC’s Distinction in Rare Diseases and Orphan Drugs. Conditions Treated Include: CLN2 Disease Molecularly Confirmed Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Duchenne Muscular Dystrophy (DMD) Mucopolysaccharidosis (MPS) Fabry Disease Paroxysmal Nocturnal Hemoglobinuria (PNH) Growth Hormone Deficiency Pompe Disease Gaucher Disease Phenylketonuria (PKU) Hereditary Angioedema (HAE) Progressive Keratoconus Hereditary ATTR (hATTR) Spinal Muscular Atrophy (SMA) Hunter Syndrome Tardive Dyskinesia Idiopathic Pulmonary Fibrosis (IPF) X-Linked Hypophosphatemia (XLH)
Advanced Clinical is a clinical development and strategic resourcing organization committed to providing a better clinical experience across the drug development journey. Our goal is to improve the lives of all those touched by clinical research – approaching each opportunity with foresight, character, resilience and innovation. Based on decades of experience, we help our clients achieve better outcomes by conducting candid conversations and anticipating potential issues through our customized solutions. Visit our website to learn more: www.advancedclinical.com.
We help health & wellness companies find their authentic edge and leverage it for growth. EnticEdge is a boutique consulting firm that brings together value-focused strategy and customer-centered design. We customize effective approaches for our clients to convert new customers and further grow their businesses. Our strategic team has decades of experience helping healthcare and wellness companies redefine their value and create compelling messaging around what differentiates them from the competition. With vast knowledge of the healthcare ecosystem, and wellness space, we advise on redefining company or division strategies around your unique value in the marketplace, building meaningful partnerships, helping align stakeholders, and successfully engaging with new innovations - from new incentive models to new technology integration.
Work Your Passion. Live Your Purpose.